Behavioral or Solifenacin Therapy for Urinary Symptoms in Parkinson Disease
Phase of Trial: Phase III
Latest Information Update: 18 Aug 2018
At a glance
- Drugs Solifenacin (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- Acronyms BOSS PD
- 06 Mar 2018 Status changed from not yet recruiting to recruiting.
- 26 Jan 2018 Planned End Date changed from 31 Dec 2020 to 31 Dec 2021.
- 26 Jan 2018 Planned primary completion date changed from 30 Jun 2020 to 31 Aug 2021.